PharmacovigilanceOfficial
FDA classes Cardinal Health Presource kit correction as Class I over recalled BD Alaris infusion sets
🇺🇸 FDA MedWatch · Tue 17 Nov 2026
The FDA has designated the correction of Presource convenience kits containing recalled BD Alaris Pump Infusion Sets as its most serious recall type, with kits to be corrected before further use.
The US Food and Drug Administration has classified Cardinal Health's correction of certain Presource convenience kits as a Class I recall, the agency's most serious category. The update, dated 16 November 2026 and published on 17 November, follows an Early Alert issued on 20 October. The FDA says the affected products and recommended actions have not changed.
Subscribe to keep reading
$4.99 / month
- Every article, analysis and opinion piece on VigiEye and CompePharma
- One subscription for both sites, cancel any time
or
Official source: FDA MedWatch ↗
Article written by VigiEye from the official source (FDA MedWatch). AI-assisted; check the source before acting.
More Pharmacovigilance
All →
FDA early alert: Tablo power cord connections may overheat, Outset Medical updates instructions
🇺🇸 FDA MedWatch · Wed 18 Nov 2026
EMA publishes list of Union reference dates and PSUR submission frequencies
🇪🇺 EMA · Wed 18 Nov 2026
EU Health Security Committee urges stronger action on carbapenem-resistant bacteria as infections rise
🇪🇺 European Commission (DG SANTE) · Wed 18 Nov 2026
AIFA starts rolling review of daraxonrasib after positive CHMP opinion in pancreatic cancer
🇮🇹 AIFA · Wed 18 Nov 2026
Portugal's antibiotic use stays below EU average, but broad-spectrum prescribing remains a concern
🇵🇹 INFARMED · Wed 18 Nov 2026
MHRA develops AdvanceGxP service to bring GxP advice into early innovation
🇬🇧 MHRA · Wed 18 Nov 2026